🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/09/2008 | 54,29 | 55,00 | 52,89 | 53,00 | -2,76% | 3,90% | 741.000 |
| 19/09/2008 | 55,25 | 56,99 | 52,01 | 54,50 | +2,83% | 9,01% | 3.302.000 |
| 18/09/2008 | 51,63 | 53,23 | 50,95 | 53,00 | +2,02% | 4,41% | 1.792.000 |
| 17/09/2008 | 54,07 | 54,73 | 51,95 | 51,95 | -5,93% | 5,14% | 1.709.400 |
| 16/09/2008 | 53,75 | 55,79 | 52,78 | 55,23 | +0,74% | 5,60% | 1.163.800 |
| 15/09/2008 | 55,01 | 56,97 | 54,27 | 54,82 | -3,25% | 4,91% | 1.388.600 |
| 12/09/2008 | 56,01 | 57,10 | 55,88 | 56,66 | +0,06% | 2,17% | 6.411.400 |
| 11/09/2008 | 55,92 | 57,05 | 55,79 | 56,63 | -0,46% | 2,25% | 1.551.600 |
| 10/09/2008 | 56,00 | 56,96 | 55,45 | 56,89 | +4,68% | 2,71% | 3.004.200 |
| 09/09/2008 | 54,51 | 55,81 | 53,95 | 54,34 | -0,70% | 3,41% | 787.200 |
| 08/09/2008 | 56,09 | 56,21 | 54,26 | 54,73 | +0,03% | 3,49% | 889.800 |
| 05/09/2008 | 53,50 | 55,14 | 52,29 | 54,71 | +1,54% | 5,32% | 1.349.600 |
| 04/09/2008 | 54,29 | 55,06 | 53,47 | 53,88 | -0,47% | 2,93% | 934.000 |
| 03/09/2008 | 53,51 | 54,15 | 52,71 | 54,14 | +1,28% | 2,69% | 1.627.600 |
| 02/09/2008 | 53,55 | 54,43 | 52,97 | 53,45 | +0,73% | 2,74% | 934.600 |
| 29/08/2008 | 52,94 | 53,73 | 52,77 | 53,07 | -0,22% | 1,82% | 643.600 |
| 28/08/2008 | 51,29 | 53,48 | 51,29 | 53,18 | +3,03% | 4,27% | 895.200 |
| 27/08/2008 | 51,89 | 51,89 | 50,54 | 51,62 | -0,64% | 2,60% | 1.192.200 |
| 26/08/2008 | 52,51 | 52,74 | 51,47 | 51,95 | -1,21% | 2,43% | 617.800 |
| 25/08/2008 | 53,34 | 53,56 | 52,06 | 52,58 | -1,17% | 2,82% | 552.000 |
| 22/08/2008 | 52,38 | 53,41 | 52,14 | 53,20 | +1,84% | 2,42% | 585.200 |
| 21/08/2008 | 51,99 | 52,49 | 51,22 | 52,24 | -0,19% | 2,44% | 754.600 |
| 20/08/2008 | 52,76 | 53,11 | 52,02 | 52,34 | -1,18% | 2,07% | 709.000 |
| 19/08/2008 | 53,50 | 53,95 | 52,63 | 52,97 | -0,91% | 2,48% | 520.000 |
| 18/08/2008 | 55,11 | 55,46 | 53,15 | 53,45 | -2,78% | 4,19% | 850.200 |
| 15/08/2008 | 55,63 | 55,80 | 54,42 | 54,98 | +0,06% | 2,49% | 971.000 |
| 14/08/2008 | 53,65 | 55,24 | 52,57 | 54,95 | +2,20% | 4,99% | 1.462.200 |
| 13/08/2008 | 54,20 | 54,43 | 53,40 | 53,76 | -1,02% | 1,90% | 1.368.000 |
| 12/08/2008 | 54,66 | 55,33 | 54,07 | 54,32 | -3,34% | 2,30% | 2.787.400 |
| 11/08/2008 | 55,66 | 56,50 | 55,18 | 56,19 | +2,43% | 2,38% | 693.600 |